Cargando…

Therapeutic Potential of Targeting Mitochondria for Alzheimer’s Disease Treatment

Alzheimer’s disease (AD), a chronic and progressive neurodegenerative disease, is characterized by memory and cognitive impairment and by the accumulation in the brain of abnormal proteins, more precisely beta-amyloid (β-amyloid or Aβ) and Tau proteins. Studies aimed at researching pharmacological t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atlante, Anna, Amadoro, Giuseppina, Latina, Valentina, Valenti, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697019/ https://www.ncbi.nlm.nih.gov/pubmed/36431219 http://dx.doi.org/10.3390/jcm11226742

Ejemplares similares

Dysfunction of Mitochondria in Alzheimer’s Disease: ANT and VDAC Interact with Toxic Proteins and Aid to Determine the Fate of Brain Cells
por: Atlante, Anna, et al.
Publicado: (2022)

Functional Foods: An Approach to Modulate Molecular Mechanisms of Alzheimer’s Disease
por: Atlante, Anna, et al.
Publicado: (2020)

COVID-19 and Alzheimer’s Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future
por: Amadoro, Giuseppina, et al.
Publicado: (2023)

Mitochondria Can Cross Cell Boundaries: An Overview of the Biological Relevance, Pathophysiological Implications and Therapeutic Perspectives of Intercellular Mitochondrial Transfer
por: Valenti, Daniela, et al.
Publicado: (2021)

Mitochondria Have Made a Long Evolutionary Path from Ancient Bacteria Immigrants within Eukaryotic Cells to Essential Cellular Hosts and Key Players in Human Health and Disease
por: Atlante, Anna, et al.
Publicado: (2023)

The Cleavage-Specific Tau 12A12mAb Exerts an Anti-Amyloidogenic Action by Modulating the Endocytic and Bioenergetic Pathways in Alzheimer’s Disease Mouse Model
por: Latina, Valentina, et al.
Publicado: (2023)

A long story for a short peptide: therapeutic efficacy of a cleavage-specific tau antibody
por: Amadoro, Giuseppina, et al.
Publicado: (2021)

Mitochondrial Complex I and β-Amyloid Peptide Interplay in Alzheimer’s Disease: A Critical Review of New and Old Little Regarded Findings
por: Atlante, Anna, et al.
Publicado: (2023)

Tau Cleavage Contributes to Cognitive Dysfunction in Strepto-Zotocin-Induced Sporadic Alzheimer’s Disease (sAD) Mouse Model
por: Latina, Valentina, et al.
Publicado: (2021)

The Intersection of NGF/TrkA Signaling and Amyloid Precursor Protein Processing in Alzheimer’s Disease Neuropathology
por: Canu, Nadia, et al.
Publicado: (2017)

Systemic delivery of a specific antibody targeting the pathological N-terminal truncated tau peptide reduces retinal degeneration in a mouse model of Alzheimer’s Disease
por: Latina, Valentina, et al.
Publicado: (2021)

Nerve Growth Factor-Based Therapy in Alzheimer’s Disease and Age-Related Macular Degeneration
por: Amadoro, Giuseppina, et al.
Publicado: (2021)

Morphological and biomolecular targets in retina and vitreous from Reelin-deficient mice (Reeler): Potential implications for age-related macular degeneration in Alzheimer’s dementia
por: Balzamino, Bijorn Omar, et al.
Publicado: (2022)

Systemic Metabolism and Mitochondria in the Mechanism of Alzheimer’s Disease: Finding Potential Therapeutic Targets
por: Song, Meiying, et al.
Publicado: (2023)

A Walk in the Memory, from the First Functional Approach up to Its Regulatory Role of Mitochondrial Bioenergetic Flow in Health and Disease: Focus on the Adenine Nucleotide Translocator
por: Atlante, Anna, et al.
Publicado: (2021)

Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer’s disease and other tauopathies
por: Florenzano, Fulvio, et al.
Publicado: (2017)

Mitochondria as a therapeutic target in Alzheimer's disease
por: Wang, Jian, et al.
Publicado: (2016)

An Intriguing Involvement of Mitochondria in Cystic Fibrosis
por: Favia, Maria, et al.
Publicado: (2019)

Transcriptomic Analysis in the Hippocampus and Retina of Tg2576 AD Mice Reveals Defective Mitochondrial Oxidative Phosphorylation and Recovery by Tau 12A12mAb Treatment
por: Morello, Giovanna, et al.
Publicado: (2023)

Mitochondria-associated membranes (MAMs): a potential therapeutic target for treating Alzheimer’s disease
por: Yu, Weiwei, et al.
Publicado: (2021)

Impaired NGF/TrkA Signaling Causes Early AD-Linked Presynaptic Dysfunction in Cholinergic Primary Neurons
por: Latina, Valentina, et al.
Publicado: (2017)

Mitochondria as Potential Targets in Alzheimer Disease Therapy: An Update
por: Cenini, Giovanna, et al.
Publicado: (2019)

Impaired adult neurogenesis is an early event in Alzheimer’s disease neurodegeneration, mediated by intracellular Aβ oligomers
por: Scopa, Chiara, et al.
Publicado: (2019)

Alzheimer's Proteins, Oxidative Stress, and Mitochondrial Dysfunction Interplay in a Neuronal Model of Alzheimer's Disease
por: Bobba, Antonella, et al.
Publicado: (2010)

The Role of Mitochondria-Derived Peptides in Cardiovascular Diseases and Their Potential as Therapeutic Targets
por: Dabravolski, Siarhei A., et al.
Publicado: (2021)

Mitochondrial Bioenergetics in Different Pathophysiological Conditions 2.0
por: Valenti, Daniela, et al.
Publicado: (2022)

Mitochondrial Bioenergetics in Different Pathophysiological Conditions
por: Valenti, Daniela, et al.
Publicado: (2021)

Targeting Mitochondria as Therapeutic Strategy for Metabolic Disorders
por: Sorriento, Daniela, et al.
Publicado: (2014)

Mitochondria Deregulations in Cancer Offer Several Potential Targets of Therapeutic Interventions
por: Musicco, Clara, et al.
Publicado: (2023)

Morphological and bioenergetic demands underlying the mitophagy in post-mitotic neurons: the pink–parkin pathway
por: Amadoro, Giuseppina, et al.
Publicado: (2014)

Mitochondria: A Therapeutic Target for Parkinson’s Disease?
por: Luo, Yu, et al.
Publicado: (2015)

Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases
por: Fernández-Moriano, Carlos, et al.
Publicado: (2015)

Disentangling Mitochondria in Alzheimer’s Disease
por: Johri, Ashu
Publicado: (2021)

Neuroinflammation as a Potential Therapeutic Target in Alzheimer’s Disease
por: Liu, Ping, et al.
Publicado: (2022)

NGF-Dependent Changes in Ubiquitin Homeostasis Trigger Early Cholinergic Degeneration in Cellular and Animal AD-Model
por: Latina, Valentina, et al.
Publicado: (2018)

Therapeutic Potentials of Microalgae in the Treatment of Alzheimer’s Disease
por: Olasehinde, Tosin A., et al.
Publicado: (2017)

Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?
por: Srinivasan, Kavya, et al.
Publicado: (2021)

Mitochondria and Mitochondrial Cascades in Alzheimer’s Disease
por: Swerdlow, Russell H.
Publicado: (2018)

Noradrenaline in Alzheimer’s Disease: A New Potential Therapeutic Target
por: Gutiérrez, Irene L., et al.
Publicado: (2022)

The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics
por: Pritchard, Susanne M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vo5ko00457b6cuuui9rmf3j0fo